ClinicalTrials.gg
CompletedNCT05244733Updated Jan 30, 2026

Culture and Well-Being for Latinos

An interventional study of Social Engage (S-ENGAGE) and The Healthy Lifestyles Education Program in Social Isolation, Loneliness and Suicidal Ideation, sponsored by University of Rochester. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-01-30.

Sponsored by University of Rochester · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
54
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 97 studies in Social Isolation with a site in United States — 26 open to participants now, 29 under way, none of them phase 3. Social Isolation · United States.

Enrollment
60th of 92
54 · median 79
Started
2022
with 8 others
No phase
89 of 97
24 open now
Registered
51st of 97
by date
Lead sponsor
9 of 97
University of Rochester

Among the 97 studies in Social Isolation with a site in United States, this one is the 60th largest by enrollment of the 92 interventional ones that give a count, is one of 9 that started in 2022, is one of 89 with no phase, and was the 51st registered.

Social Isolation

236 studies on the registry are indexed under Social Isolation; 61 are open to participants now.

This study's enrollment of 54 is below the median of 80 across 198 interventional studies indexed under Social Isolation.

Browse Social Isolation studies →

Open to participants now

26 of the 97 studies in Social Isolation with a site in United States are open now.

All 26 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 34 Social Isolation studies recruiting now, 22 (65%) set no upper age limit and 6 (18%) stop at 75 or younger; 4 take children under 18; 18 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →
Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 97 studies in Social Isolation with a site in United States, or all of them as a file.
02

Study summary

The proposed K23 study is an intervention study using an experimental therapeutics approach. This pilot RCT asks: "Does SOCIAL-ENGAGE increase cultural-social engagement and decrease suicide risk among Spanish-speaking adults?" We will first optimize a behavioral intervention - SOCIAL ENGAGE (S-ENGAGE) - for target engagement using human-centered design approaches with Spanish-speaking adults at risk for suicide (n=5) and then conduct a pilot RCT (n=60) to test target engagement (cultural-social engagement) and clinical impact (suicide risk) of S-ENGAGE with this population. The ultimate goal is for S-ENGAGE to be offered as a suicide prevention program for Hispanics at risk for suicide.

03

Conditions studied

  • Social Isolation
  • Loneliness
  • Suicidal Ideation
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Identify as Hispanic/Latino adult (age 18+);
  • Primary Spanish-Speaker;
  • Patient in the UR health system;
  • Low cultural-social engagement (i.e., score ≤ 2 on the adapted Berkman-Syme Social Network Index);
  • Elevated suicide risk (i.e., presence of passive or active suicide ideation in the past month on the Columbia-Suicide Severity Rating Scale [C-SSRS]).

Exclusion criteria

Exclusion Criteria:

  • Medical or psychiatric comorbidities that impair ability to consent (e.g., active psychotic or manic episode, cognitive impairment).
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
54 participants (actual)

Study arms

  • Experimental
    Social Engage (S-ENGAGE)

    S-ENGAGE is a skills-based psychotherapy that focuses on helping patients engage in meaningful rewarding social activities. Subjects will receive 10 one-hour individual sessions of S-ENGAGE over 10 weeks.

    Behavioral: Social Engage (S-ENGAGE)

  • Placebo comparator
    The Healthy Lifestyles Education Program

    The healthy lifestyles education program consists of a notebook containing evidence-based educational material on mental health, physical activity, and information on community resources. Study staff meet with participants once, individually, for 1 hour to review each section and answer questions participants might have.

    Behavioral: The Healthy Lifestyles Education Program

Interventions

  • BehavioralSocial Engage (S-ENGAGE)

    S-ENGAGE uses the process of action planning to foster sustained behavior change. Action planning involves: 1) select a goal; 2) develop ideas to meet this goal; 3) choose one or more of these ideas; 4) identify concrete steps to implement the goal (i.e., form an action plan); 5) identify and address barriers if needed.

  • BehavioralThe Healthy Lifestyles Education Program

    The healthy lifestyles education program is a self-guided psychoeducational program, including a notebook containing evidence-based educational material on mental health, physical activity, and information on community resources.

06

What researchers measure

Primary outcomes

  1. Change in Cultural-Social Engagement (A)

    Average number of cultural-social interactions (measured via EMA), with greater number indicating greater cultural-social engagement (i.e., better outcome).

    Time frame: Baseline and 10 weeks

  2. Change in Cultural-Social Engagement (B)

    Time spent in positive Spanish-language conversations (measured via passive monitoring of conversations), with more time indicating greater cultural-social engagement (i.e., better outcome).

    Time frame: Baseline and 10 weeks

  3. Change in Cultural-Social Engagement (C)

    Number of visits to cultural-social settings outside the home (measured via GPS), with greater number indicating greater cultural-social engagement (i.e., better outcome).

    Time frame: Baseline and 10 weeks

  4. Change in Cultural-Social Engagement (D)

    Self-reported feelings of belonging to Hispanic cultural groups (measured via EMA with the Interpersonal Needs Questionnaire), with greater scores indicating greater cultural-social engagement (i.e., better outcome).

    Time frame: Baseline and 10 weeks

Secondary outcomes

  1. Change in Suicide Risk (A)

    Reasons for living total score, measured by the Reasons for Living Inventory, with 48 items rated from 1 to 6, with greater scores indicating greater importance for reasons for living (i.e., better outcome).

    Time frame: Baseline and 10 weeks

  2. Change in Suicide Risk (B)

    Suicide ideation total score, measured by the Beck Scale for Suicide Ideation, with scores ranging from 0 to 38, with greater scores indicating greater suicide ideation (i.e., worse outcome).

    Time frame: Baseline and 10 weeks

07

Study locations

1 site
  • University of Rochester Medical Center
    Rochester, New York 14642, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jun 2022 to primary completion in Sep 2025, 39 months.

Of 155 non-industry interventional studies with no phase under Social Isolation, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 36. This study's 39 months is above that.

Counting every sponsor, half of 156 studies reached it within 18 months; a quarter within 10 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 8, 2022
First posted
Feb 17, 2022
StartActual
Jun 1, 2022
Primary completionActual
Sep 19, 2025
CompletionActual
Sep 19, 2025
Last update
Jan 30, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 30, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05244733
Responsible party
Caroline Silva (Assistant Professor, University of Rochester) — Principal investigator
First posted
Feb 17, 2022
Start date
Jun 1, 2022
Primary completion
Sep 19, 2025
Completion
Sep 19, 2025
Last update
Jan 30, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion